A LIVING cancer drug has been proven to work against solid tumours for the first time. Immune-boosting CAR-T therapy removes ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

The immunotherapy, which involves using white blood cells to attack foreign cells, has been heralded as ‘groundbreaking’ by ...

Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy ...

Zivanov, assistant professor of electrical and computer engineering, has received a prestigious Faculty Early Career ...

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

During a live event, Konstantinos Sdrimas, MD, asked participants what community oncologists should consider when referring ...

Researchers sought to determine whether lisocabtagene maraleucel would have efficacy for patients with LBCL in a real-world setting.

BHUBANESWAR: The incidence of blood cancer or leukaemia in the country is on the upward spiral with a high number of children getting afflicted by the disease, ...

Overcoming current limitations and expanding the reach of CAR-T therapeutics could unlock promising new treatment ...

India is witnessing a significant rise in cases of blood cancer, or leukemia, among children, according to a medical expert.